Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > They sold shares on that earnings report?!?! Unbelievable

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Oct 14, 2021 3:11pm

116 Views

Post# 34006488

RE:RE:RE:They sold shares on that earnings report?!?! Unbelievable

There hasn't been any insider transactions since August.
https://m.canadianinsider.com/company?ticker=TH

Wino115 wrote: It could be from exercise of stock options by employees and any number of other things for something on the small side. But nice pickup of info. Let's see.

This is a period where insiders can buy and frankly I would like to see a lot of buying by insiders at this juncture -- within weeks of announcing something that could change the entire trajectory of the business. If we see none, it just begs the question what do they know that we don't?

PWIB123 wrote: Where did you get that info?